A Study of ZL-1310 in Participants With Selected Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of ZL-1310 in Participants With Selected Solid Tumors	Solid Tumors	Recruiting	Phase 1 / Phase 2	2026-08-21		NCT06885281

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Zai Lab (Shanghai) Co., Ltd.	12
Zai Lab (US) LLC	5

23 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Cancer Hospital	Beijing	China	208
Beijing GoBroad Hospital	Beijing	China	14
Fox Chase Cancer Center	Philadelphia	United States	259
Fudan University Shanghai Cancer Center	Shanghai	China	27
Harbin Medical University Cancer Hospital	Harbin	China	102
Huashan Hospital Fudan University	Shanghai	China	18
Hunan Cancer Hospital	Changsha	China	123
Jilin Cancer Hospital	Changchun	China	31
Karmanos Cancer Center	Detroit	United States	16
Memorial Sloan-Kettering Cancer Center	New York	United States	63
OSF St. Francis Medical Center	Peoria	United States	9
SCRI OP (Oncology Partners)	Nashville	United States	2
Shanghai Pulmonary Hospital	Shanghai	China	72
Sun Yat-sen university cancer center	Guangzhou	China	5
Texas Oncology - Central South	McAllen	United States	4
Texas Oncology / Sammons Cancer Center	Dallas	United States	1
The First Affiliated hospital of Xiamen University	Xiamen	China	69
The First Affiliated Hospital, Sun Yat-sen University	Guangzhou	China	32
The University of Texas M. D. Anderson Cancer Center	Houston	United States	88
University Hospitals Cleveland Medical Center	Cleveland	United States	234
University of California San Francisco/Helen Diller Family Comprehensive Cancer Center	San Francisco	United States	1
Virginia Cancer Specialists	Fairfax	United States	109
Virginia Oncology Associates	Norfolk	United States	73

Clinical trials